Is a lower versus higher phosphate target beneficial to patients undergoing hemodialysis?
Check out this crisp VA by Dr Sejal Lakhani
Can rivaroxaban improve cardiovascular outcomes in patients with advanced CKD.? Although vascular inflammation and thrombosis are at the heart of CV damage, anticoagulants have not previously shown benefits in CVD patients.
This week, NephJC will discuss whether obinutuzumab is ready to outperform tacrolimus in primary membranous nephropathy
In this edition of NephJC, we discuss the largest case series of kidney biopsies in patients with Diabetes.
This week we will discuss whether a bundled, team-based hypertension intervention- featuring intensive BP targets, home monitoring, health coaching, and audit feedback- can overcome poverty, clinical inertia, and fragmented care to improve blood pressure control in low-income patients receiving care at federally qualified health centers.
Is a lower versus higher phosphate target beneficial to patients undergoing hemodialysis?
Check out this crisp VA by Dr Sejal Lakhani
Based on data from the CRIC study, this analysis dives deep into whether this lab mismatch is just noise… or a clinical signal we’ve been missing.
Check out the beautiful visual abstract made by our NephJC interns Sai Vani Yellampalli and Akshaya Jayachandran. Great team work!!!
Check out the beautiful visual abstract made by NephJC intern Michelle Fravel.
Check out the beautiful visual abstract made by Kajaree Giri
Check out the beautiful visual abstract made by NephJC faculty Dr Divyia Bajpai
Nephrotic syndrome in kids can mean frequent relapses, high steroid burden, and tough treatment choices. So which helps maintain remission better: Tacrolimus or MMF?
See the Visual Abstract Krithika Mohan
Nephrotic syndrome in children, especially those with frequent relapses or steroid dependence, remains a therapeutic challenge. The STAMP trial compared tacrolimus and mycophenolate mofetil to help guide treatment decisions.
Stunning visual abstract summarizing NEJM study, by Priti Meena
Does desmopressin reduce the risjk of post kidney biopsy bleeding? Checkout the beautiful VA answering this practical question by NSMC faculty Dr Divya Bajpai.
What is the effect of microvascular inflammation on kidney allografts? Checkout the crisp VA by NSMC faculty Dr Divya Bajpai.
Should we continue metformin in eGFR under 30 ml/min? The visual abstract by Cristina Popa summarizes the conclusions from the Scottish cohort using target trial methodology.
The KDIGO ADPKD guideline is a result of a decade of global collaboration between physicians, researchers, advocates, and patients. 240 pages summarized in only 2 pictures, made by Cristina Popa.
Is Obinutuzumab Effective and Safe in Active Lupus Nephritis? Check out the beautiful VA by NSMC Faculty Dr Divya Bajpai on the REGENCY Trial, answering the same.
Do Mineralocorticoid Receptor Antagonists Preclude the Identification of Unilateral Primary Aldosteronism at Adrenal Venous Sampling?
Guidelines recommend withholding MRAs prior to PA subtyping by AVS. Is it worth the risk of hypokalemia and hypertension? NSMC Faculty Dr Divya Bajpai answers with a crisp VA
Can we train to deal with the pain? HOPE trial shows us that non-pharmacological intervention can be an option. Visual abstract by Cristina Popa
Does initiation of ACEi and ARB help in advanced CKD? Check out the VA by Dr Nikhil John
In patients with hyperkalemia on maintenance hemodialysis, whether a combination of higher dialysate potassium with SZC can reduce the rates of AF and other clinically significant arrhythmias? Check out the VA by Madiha Aziz